Global Assembly Puts Off “Fake” Drug Definition Opposed By India
This article was originally published in PharmAsia News
Executive Summary
The World Health Assembly has rejected temporarily a global definition of what constitutes counterfeit drugs, providing relief to Indian generics makers. Indian health activists and the government feared the assembly would adopt a proposed definition that would cover generics as well as fake drugs as part of an effort to reduce the surfeit of counterfeits. The assembly suggested its executive board take a closer look at the International Medical Products Anti-Counterfeiting Taskforce definition opposed by Indian drug makers and their government. Their objection is to the part that determines a medical product counterfeit when "there is a false representation in relation to its identity, history or source, applying to the product, its container, packaging or other labeling information." (Click here for more